- Report
- September 2025
- 269 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 167 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 413 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 167 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 353 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 172 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 114 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 264 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 208 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 456 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 213 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 578 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 122 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 340 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 258 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- September 2025
- 196 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- June 2025
- 404 Pages
Global
From €5171EUR$5,850USD£4,474GBP
- Report
- October 2025
Global
From €4331EUR$4,900USD£3,747GBP
- Report
- September 2025
Global
From €4331EUR$4,900USD£3,747GBP
- Report
- September 2025
Global
From €4331EUR$4,900USD£3,747GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more